Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM).
https://mma.prnewswire.com/media/1733185/Shareholders_Foundation_Logo_Logo.jpg
Investors who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) prior to October 2022 and continue to hold any of those NYSE: ATNM shares also have certain options and contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
On March 27, 2025, a NYSE: ATNM investor filed a lawsuit against Actinium Pharmaceuticals, Inc. over alleged violations of securities laws. The plaintiff alleged that the Defendants failed to disclose that the Company's data from the Sierra Trial was unlikely to satisfy the FDA's guidelines for the acceptance and approval of Iomab-B BLA, that the additional analyses, including long-term follow-ups that purportedly demonstrated a trend towards improved Overall Survival that the Company provided to the FDA in an attempt to mitigate Sierra's poor OS data were unlikely to satisfy the FDA's guidelines for the acceptance and approval of Iomab-B BLA, that as a result, the FDA would likely refuse to review the Iomab-B BLA or, if it did consider that BLA, that the application in its current form was unlikely to be approved, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) should contact the Shareholders Foundation, Inc.
CONTACT:Shareholders Foundation, Inc.Michael Daniels+1 (858) 779-1554mail@shareholdersfoundation.com3111 Camino Del Rio NorthSuite 423San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
https://c212.net/c/img/favicon.png?sn=DC76495&sd=2025-04-30
View original content to download multimedia:https://www.prnewswire.com/news-releases/lawsuit-for-investors-in-shares-of-actinium-pharmaceuticals-inc-nyse-atnm-announced-by-the-shareholders-foundation-302442087.html
SOURCE Shareholders Foundation, Inc.
https://rt.newswire.ca/rt.gif?NewsItemId=DC76495&Transmission_Id=202504300725PR_NEWS_USPR_____DC76495&DateId=20250430